Protega Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PROTEGA PHARMS, and when can generic versions of PROTEGA PHARMS drugs launch?
PROTEGA PHARMS has one approved drug.
There are two US patents protecting PROTEGA PHARMS drugs.
There are twenty-two patent family members on PROTEGA PHARMS drugs in ten countries and one supplementary protection certificate in one country.
Drugs and US Patents for Protega Pharms
International Patents for Protega Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 6608319 | ⤷ Try a Trial |
Australia | 2008286914 | ⤷ Try a Trial |
Canada | 2734075 | ⤷ Try a Trial |
Canada | 2923102 | ⤷ Try a Trial |
Japan | 2010536770 | ⤷ Try a Trial |
Mexico | 2010001812 | ⤷ Try a Trial |
Australia | 2019200895 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Protega Pharms Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1685839 | 92292 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.